Ori Choshen

SafePeak Technologies Ltd. (US) developed a plug and play software solutions. The company was founded in 2007 and was headquartered Westwood, MA.

SanDisk LLC designs, develops and markets flash memory data storage products. The company was founded by Eli Harari and Sanjay Mehrotra on June 01, 1988 and is headquartered in Irvine, CA.

msystems Ltd. develops, manufactures, and markets flash data storage solutions for the digital consumer electronics markets. Its products include mDrive and various USB-enabled devices, mDOC embedded flash drives for mobile handsets and consumer electronics devices. The company was founded in 1989 and is located in Kfar Saba, Israel.

PFC, Inc. manufactures boating designs and services. The company was founded in 1979 and is headquartered in Hartsville, SC.

Xenia Venture Capital Ltd. engages in initiation and building of technological companies in the areas of information technology and medical devices. It provides start-ups with professional and supportive environment, including assistance in all business development and company development aspects, follow-on fund raising, strategic counseling,peripheral services pertaining to logistics, finance, and office services. The company was founded in 2004 and is headquartered in Tel Aviv, Israel.

Saguna Networks Ltd. provides mobile content delivery solutions. The firm offers Saguna Open-RAN product. It offers content optimization delivery system, a carrier grade system, providing content caching and acceleration designed to meet the demand of content over WiMAX(TM) networks. The company was founded by Lior Fite and Danny Frydman in 2008 and is headquartered in Yokneam, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

Pyxis Diagnostics Ltd. was founded in 2019 and is based in Jerusalem, Israel. The Israeli company's mission is to identify patients who are likely to respond to immunotherapy and to discover new targets and drug combinations to treat those who do not. The company achieves this by leveraging their ability to delineate the immune-tumor-stroma communication networks.